ACM

Abrams Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,996,836	Closed	-$62.6M	–	14
2023 Q4	$62.6M	Sell	5,996,836 -1,969,597	-25%	-$20.6M	1.95%	11
2023 Q3	$81.3M	Hold	7,966,433	–	–	2.68%	11
2023 Q2	$60M	Hold	7,966,433	–	–	1.73%	13
2023 Q1	$70.5M	Sell	7,966,433 -7,966,432	-50%	-$70.5M	2.23%	12
2022 Q4	$145M	Sell	15,932,865 -7,966,431	-33%	-$72.7M	5.18%	10
2022 Q3	$193M	Sell	23,899,296 -147,060	-0.6%	-$1.19M	5.56%	10
2022 Q2	$181M	Hold	24,046,356	–	–	4.86%	11
2022 Q1	$226M	Hold	24,046,356	–	–	5.27%	12
2021 Q4	$193M	Hold	24,046,356	–	–	4.23%	12
2021 Q3	$234M	Hold	24,046,356	–	–	5.11%	9
2021 Q2	$238M	Hold	24,046,356	–	–	5.29%	9
2021 Q1	$277M	Hold	24,046,356	–	–	6.25%	7
2020 Q4	$232M	Hold	24,046,356	–	–	6.54%	8
2020 Q3	$217M	Hold	24,046,356	–	–	6.85%	6
2020 Q2	$296M	Hold	24,046,356	–	–	9.58%	2
2020 Q1	$216M	Hold	24,046,356	–	–	8.5%	3
2019 Q4	$236M	Hold	24,046,356	–	–	7.32%	5
2019 Q3	$165M	Buy	24,046,356 +6,000,000	+33%	+$41.3M	4.63%	12
2019 Q2	$167M	Hold	18,046,356	–	–	4.52%	10
2019 Q1	$283M	Sell	18,046,356 -476,016	-3%	-$7.46M	7.95%	5
2018 Q4	$286M	Sell	18,522,372 -1,000,000	-5%	-$15.4M	11.8%	3
2018 Q3	$421M	Sell	19,522,372 -220,751	-1%	-$4.75M	11.12%	1
2018 Q2	$480M	Hold	19,743,123	–	–	13.36%	1
2018 Q1	$337M	Hold	19,743,123	–	–	10.58%	2
2017 Q4	$374M	Sell	19,743,123 -1,880,763	-9%	-$35.6M	12.6%	2
2017 Q3	$381M	Buy	+21,623,886	New	+$381M	14.85%	2
2013 Q3	–	Sell	-2,561,269	Closed	-$100M	–	13
2013 Q2	$100M	Buy	+2,561,269	New	+$100M	5.81%	6